← back to search

Huyang Xie

Shanghai Medical College of Fudan University · CN
🔎 Find collaborators in Surgery · Oncology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Surgery · Oncology
Research interest
Research interests include Medicine, Clear cell renal cell carcinoma, Cancer research, Bladder cancer, Renal cell carcinoma, and Immune system.
h-index
citations
773
works
10
NIH funding
primary concept
email

Recent publications

Predictive value of inflammatory marker PLR in prostate cancer
BMC Urology 2025cited by 2position: lastdoi
Molecular subtypes based on metabolic genes are potential biomarkers for predicting prognosis and immune responses of clear cell renal cell carcinoma
European Journal of Immunology 2022cited by 8position: lastdoi
Retinoic Acid–Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer
Cancer Research 2019cited by 153position: middledoi
MiR-455-5p Suppresses the Progression of Prostate Cancer by Targeting CCR5
BioMed Research International 2019cited by 52position: middledoi
Development and External Validation of a Novel 12-Gene Signature for Prediction of Overall Survival in Muscle-Invasive Bladder Cancer
Frontiers in Oncology 2019cited by 19position: middledoi
Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion
European Urology 2018cited by 205position: middledoi
Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer
Clinical Cancer Research 2018cited by 199position: middledoi
Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer
OncoImmunology 2018cited by 75position: middledoi
High mucin 5AC expression predicts adverse postoperative recurrence and survival of patients with clear-cell renal cell carcinoma
Oncotarget 2017cited by 9position: middledoi
Tumor Infiltrating Mast Cells (TIMs) Confers a Marked Survival Advantage in Nonmetastatic Clear-Cell Renal Cell Carcinoma
Annals of Surgical Oncology 2016cited by 51position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Bo Dai · Fudan University5 papers (2016–2019)Jiejie Xu · Shanghai Medical College of Fudan University5 papers (2016–2018)Dingwei Ye · Fudan University4 papers (2016–2019)Hangcheng Fu · The First Affiliated Hospital, Sun Yat-sen University4 papers (2016–2018)Junyu Zhang · Fudan University4 papers (2016–2018)Yu Zhu · Fudan University4 papers (2016–2018)Qiang Fu · Fudan University3 papers (2017–2018)Yijun Shen · Fudan University2 papers (2019–2019)Qianwei Xing · Nantong University2 papers (2019–2022)Bingye Zhu · Nantong University2 papers (2019–2022)Zheng Liu · Shanghai Medical College of Fudan University2 papers (2018–2018)Yiping Zhu · State Key Laboratory of Medicinal Chemical Biology2 papers (2019–2019)Quan Zhou · Fudan University2 papers (2018–2018) · 2 papers (2016–2018)Le Xu · Shandong University of Technology2 papers (2018–2018)Zewei Wang · Sun Yat-sen University1 papers (2016–2016)Fangning Wan · Shanghai Medical College of Fudan University1 papers (2019–2019)Yangyang Qi · Nanjing Audit University1 papers (2018–2018)Dalong Cao · Fudan University1 papers (2019–2019)Dengfu Yao · Nantong University1 papers (2017–2017)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Surgery · Oncology →